Outcomes
Yale Cancer Center and our partner, Smilow Cancer Hospital, acknowledge the seven American Society of Clinical Oncology (ASCO) and National Comprehensive Cancer Network (NCCN) evidence-based quality guidelines for breast and colorectal cancers. The latest performance data for colorectal cancer is listed below.
| Colorectal Measures | Expected Estimated Performance Rates (percentage) | Yale Performance 2012 | Yale Performance 2013 | Yale Performance 2014 |
| Adjuvant chemotherapy is considered or administered within 4 months (120 days) of diagnosis for patients under the age of 80 with AJCC stage III (lymph node positive) colon cancer (Accountability) | 90% | 95.00 | 100.00 | 90.60 |
**Higher percentage is better
